BioSpace News Archive

Biotech Beach

Daré Bioscience Announces Upcoming Webinar to Review Additional Data from Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a virtual Key Opinion Leader (KOL) webinar on Tuesday, July 11, 2023, at 4:30 p.m. EDT.

July 6, 2023
·
5 min read
Drug Development

Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the first patient has been dosed in the Company’s Phase 2 subcutaneous study of barzolvolimab in eosinophilic esophagitis (EoE).

July 6, 2023
·
6 min read
BioMidwest

PaxMedica Grants Exclusive Pharmacy Distribution Rights for PAX-101 to Vox Nova, LLC

PaxMedica, Inc. (Nasdaq: PXMD) and Vox Nova LLC (VoxNova), a privately held corporation, today announced that they have signed an exclusive pharmacy distribution agreement for PaxMedica’s lead pipeline asset, PAX-101.

July 6, 2023
·
6 min read
Pharm Country

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at Global Food Allergy Prevention Summit

Aquestive Therapeutics, Inc. today announced that two posters recapping the positive data from pharmacokinetic and pharmacodynamic studies of Anaphylm epinephrine sublingual film will be presented at the Global Food Allergy Prevention Summit (GFAPS 2023), which will be held from July 7-9 in Chicago, IL.

July 6, 2023
·
6 min read
Policy

ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More

ViaDerma, Inc. is very pleased to announce several exciting business updates for current and prospective shareholders, partners, and healthcare providers.

July 6, 2023
·
3 min read
Genetown

T2 Biosystems Announces Conversion of Approximately Twenty Percent of CRG Term Loan into Equity

T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the conversion of approximately 20% of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems common stock and Series B convertible preferred stock.

July 6, 2023
·
4 min read
Drug Development

Vaxart Announces Positive Preliminary Topline Data from Dose-Ranging Phase 2 Study of its Bivalent Norovirus Vaccine Candidate

Vaxart, Inc. (Nasdaq: VXRT) today announced positive topline data from the dose-ranging Phase 2 clinical trial of its oral pill bivalent norovirus vaccine candidate.

July 6, 2023
·
8 min read
Business

AbbVie to Host Second-Quarter 2023 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its second-quarter 2023 financial results on Thursday, July 27, 2023, before the market opens.

July 6, 2023
·
1 min read
Deals

Curis Announces $15.1 Million Registered Direct Offering

Curis, Inc. today announced that it has entered into definitive agreements led by existing investors for the purchase of 18.4 million of its shares of common stock at a purchase price of $0.82 per share in a registered direct offering priced at-the-market under Nasdaq rules.

July 6, 2023
·
5 min read
Bio NC

CoImmune Announces Publication of Review of Clinical Development Program for CMN-001 in Metastatic Renal Cell Carcinoma

CoImmune, Inc. today announced the publication of a review of the company’s clinical development program evaluating CMN-001, a dendritic cell-based immunotherapy electroporated with autologous tumor RNA to treat metastatic renal cell carcinoma (mRCC).

July 6, 2023
·
3 min read